Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Extra-intestinal Microbiome
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1440017
This article is part of the Research Topic Microbiota in Tumors: Is it a New Hope for Treatment? View all articles

Diagnostic and Prognostic Potential of the Intra-tumoral Microbiota Profile in HPV-Independent Endocervical Adenocarcinoma

Provisionally accepted
Xin Zhou Xin Zhou 1,2Lili Chen Lili Chen 1*Wanrun Lin Wanrun Lin 3*Wenxin Zheng Wenxin Zheng 4Huijuan Zhang Huijuan Zhang 2,5*Feng Zhou Feng Zhou 2,5*
  • 1 Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
  • 2 International Peace Maternity and Child Health Hospital, Shanghai, Shanghai Municipality, China
  • 3 National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
  • 4 Harold C Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States
  • 5 Shanghai Key Laboratory of Embryo Original Diseases, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China

The final, formatted version of the article will be published soon.

    Microbial community dynamics have been involved in numerous diseases, including cancer. The diversity of intertumoral microbiota in human papillomavirus independent endocervical adenocarcinoma (HPVI ECA) is not well-characterized. Our objective is to delineate the intratumoral microbiota profile in HPVI ECA and investigate its potential influence on oncogenesis. We analyzed 45 HPVI ECA cases, comprising 36 gastric-type ECA (GEA) and 9 clear cell carcinomas (CCC). We compared the microbial composition within cancerous and adjacent noncancerous tissue samples using 5R-16S ribosomal DNA sequencing. Further, we investigated the correlation between specific microbes and clinical-pathological metrics as well as patient outcomes. Our findings demonstrate notable differences in the microbial spectra between cancerous and adjacent noncancerous tissues. Amongst HPVI ECA subtypes, GEAs exhibit more microbial variations compared to CCCs. Using the Random Forest algorithm, we identified two distinct microbial signatures that could act as predictive biomarkers for HPVI ECA and differentiate between GEA and CCC. Varied microbial abundances was related to clinical characteristics of HPVI ECA patients. In addition, high levels of Micrococcus and low levels of unknown genus75 from the Comamonadaceae family were associated with poorer outcomes in HPVI ECA patients. Similarly, an abundance of Microbacterium correlated with reduced overall survival (OS), and a high presence of Streptococcaceae family microbes was linked to reduced recurrence-free survival (RFS) in GEA patients. Intriguingly, a high abundance of Micrococcus was also associated with a worse OS in GEA patients. The study reveals distinct microbial signatures in HPVI ECA, which have potential as biomarkers for disease prognosis. The correlation between these tumor-associated microbiota features and clinicopathological characteristics underscores the possibility of microbiome-based interventions. Our research provides a foundation for more in-depth studies into the cervical microbiome’s role in HPVI ECA.

    Keywords: cervical cancer, Gastric-type endocervical adenocarcinoma, clear cell carcinomas, intratumoral microbiota, prognosis

    Received: 28 May 2024; Accepted: 24 Jul 2024.

    Copyright: © 2024 Zhou, Chen, Lin, Zheng, Zhang and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lili Chen, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Wanrun Lin, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
    Huijuan Zhang, International Peace Maternity and Child Health Hospital, Shanghai, 200000, Shanghai Municipality, China
    Feng Zhou, International Peace Maternity and Child Health Hospital, Shanghai, 200000, Shanghai Municipality, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.